{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:11:31Z","timestamp":1792782691566,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Zhejiang Provincial Natural Science Foundation of China","award":["LY23H080003"],"award-info":[{"award-number":["LY23H080003"]}],"id":[{"id":"https:\/\/ror.org\/04aqat463","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-026-07272-x","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T10:15:03Z","timestamp":1789380903000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Outcomes of gastrointestinal bleeding events after first-line chemotherapy in gastrointestinal-diffuse large B-cell lymphoma: a propensity-score matched analysis"],"prefix":"10.1007","volume":"105","author":[{"given":"Hui","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzhen","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanhuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haige","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"key":"7272_CR1","doi-asserted-by":"publisher","first-page":"5345","DOI":"10.2147\/ott.S248381","volume":"13","author":"C Tian","year":"2020","unstructured":"Tian C, Li Y, Chen Z (2020) A Retrospective Analysis of Primary Gastrointestinal Non-Hodgkin Lymphomas: Clinical Features, Prognostic Factors and Treatment Outcomes. Onco Targets Ther 13:5345\u20135352. https:\/\/doi.org\/10.2147\/ott.S248381","journal-title":"Onco Targets Ther"},{"key":"7272_CR2","doi-asserted-by":"publisher","unstructured":"Alvarez-Lesmes J, Chapman JR, Cassidy D et al (2021) Gastrointestinal Tract Lymphomas: A Review of the Most Commonly Encountered Lymphomas. Archives of Pathology & Laboratory Medicine. ;145(12):1585\u20131596. https:\/\/doi.org\/10.5858\/arpa.2020-0661-RA %J Archives of Pathology & Laboratory Medicine","DOI":"10.5858\/arpa.2020-0661"},{"issue":"1","key":"7272_CR3","doi-asserted-by":"publisher","first-page":"2193423","DOI":"10.1080\/07853890.2023.2193423","volume":"55","author":"Y Feng","year":"2023","unstructured":"Feng Y, Duan TJ, Huang Q et al (2023) The clinicopathological characteristics of gastric cancer and precancerous conditions in gastric DLBCL and MALT lymphoma patients: a multi-center retrospective study. Annals medicine Dec 55(1):2193423. https:\/\/doi.org\/10.1080\/07853890.2023.2193423","journal-title":"Annals medicine Dec"},{"key":"7272_CR4","doi-asserted-by":"publisher","first-page":"107406","DOI":"10.1016\/j.leukres.2023.107406","volume":"135","author":"Q Lai","year":"2023","unstructured":"Lai Q, Zhao Y, Yan H, Peng H (2023) Advances in diagnosis, treatment and prognostic factors of gastrointestinal DLBCL. Leukemia research Dec 135:107406. https:\/\/doi.org\/10.1016\/j.leukres.2023.107406","journal-title":"Leukemia research Dec"},{"key":"7272_CR5","doi-asserted-by":"publisher","unstructured":"Tran QT, Nguyen Duy T, Nguyen-Tran BS et al (2023) Endoscopic and Histopathological Characteristics of Gastrointestinal Lymphoma: A Multicentric Study. Diagnostics (Basel) Aug 26(17). https:\/\/doi.org\/10.3390\/diagnostics13172767","DOI":"10.3390\/diagnostics13172767"},{"key":"7272_CR6","doi-asserted-by":"publisher","first-page":"1447020","DOI":"10.3389\/fonc.2024.1447020","volume":"14","author":"GS Manzar","year":"2024","unstructured":"Manzar GS, Cha EE, Corrigan KL et al (2024) Outcomes and toxicities in patients with diffuse-large B cell lymphoma involving the gastrointestinal tract and digestive organs. Front Oncol 14:1447020. https:\/\/doi.org\/10.3389\/fonc.2024.1447020","journal-title":"Front Oncol"},{"issue":"11","key":"7272_CR7","doi-asserted-by":"publisher","first-page":"4409","DOI":"10.4251\/wjgo.v16.i11.4409","volume":"15","author":"XH Liu","year":"2024","unstructured":"Liu XH, Chen G, Cao DD et al (2024) Comparison of clinical features of patients with or without severe gastrointestinal complications in aggressive gastrointestinal lymphomas. World J Gastrointest Oncol Nov 15(11):4409\u20134423. https:\/\/doi.org\/10.4251\/wjgo.v16.i11.4409","journal-title":"World J Gastrointest Oncol Nov"},{"issue":"5","key":"7272_CR8","doi-asserted-by":"publisher","first-page":"100176","DOI":"10.1016\/j.slast.2024.100176","volume":"29","author":"C Huang","year":"2024","unstructured":"Huang C, Hu H, Zheng X (2024) Application effect of 18F-FDG PET\/CT technique in diagnosis and prognosis evaluation of lymphoma. SLAS technology Oct 29(5):100176. https:\/\/doi.org\/10.1016\/j.slast.2024.100176","journal-title":"SLAS technology Oct"},{"key":"7272_CR9","doi-asserted-by":"publisher","first-page":"109793","DOI":"10.1016\/j.ejrad.2021.109793","volume":"141","author":"L Zanoni","year":"2021","unstructured":"Zanoni L, Mattana F, Calabr\u00f2 D et al (2021) Overview and recent advances in PET\/CT imaging in lymphoma and multiple myeloma. European J radiology Aug 141:109793. https:\/\/doi.org\/10.1016\/j.ejrad.2021.109793","journal-title":"European J radiology Aug"},{"issue":"8","key":"7272_CR10","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.3109\/0284186x.2014.927074","volume":"53","author":"X Wu","year":"2014","unstructured":"Wu X, Pertovaara H, Korkola P et al (2014) Early interim PET\/CT predicts post-treatment response in diffuse large B-cell lymphoma. Acta Oncol (Stockholm Sweden) Aug 53(8):1093\u20131099. https:\/\/doi.org\/10.3109\/0284186x.2014.927074","journal-title":"Acta Oncol (Stockholm Sweden) Aug"},{"issue":"1","key":"7272_CR11","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1186\/s12880-025-01937-1","volume":"17","author":"E Tr\u00e4g\u00e5rdh","year":"2025","unstructured":"Tr\u00e4g\u00e5rdh E, Lewold M, Urdaneta JL et al (2025) Inter-reader agreement of quantitative FDG PET\/CT biomarkers in lymphoma: a multicentre evaluation of MTV, TLG and Dmax. BMC Med imaging Sep 17(1):368. https:\/\/doi.org\/10.1186\/s12880-025-01937-1","journal-title":"BMC Med imaging Sep"},{"issue":"1","key":"7272_CR12","doi-asserted-by":"publisher","first-page":"12748","DOI":"10.1038\/s41598-020-69550-6","volume":"29","author":"CH Lim","year":"2020","unstructured":"Lim CH, Hyun SH, Moon SH, Cho YS, Choi JY, Lee KH (2020) Comparison of the prognostic values of (18)F-fluorodeoxyglucose parameters from colon and non-colon sites of involvement in diffuse large B-cell lymphoma of the colon. Scientific reports Jul 29(1):12748. https:\/\/doi.org\/10.1038\/s41598-020-69550-6","journal-title":"Scientific reports Jul"},{"issue":"2","key":"7272_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1179\/1607845415y.0000000033","volume":"21","author":"M Xie","year":"2016","unstructured":"Xie M, Zhai W, Cheng S, Zhang H, Xie Y, He W (2016) Predictive value of F-18 FDG PET\/CT quantization parameters for progression-free survival in patients with diffuse large B-cell lymphoma. Hematology (Amsterdam Netherlands) Mar 21(2):99\u2013105. https:\/\/doi.org\/10.1179\/1607845415y.0000000033","journal-title":"Hematology (Amsterdam Netherlands) Mar"},{"issue":"1","key":"7272_CR14","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1186\/s12885-024-12668-x","volume":"25","author":"S Cui","year":"2024","unstructured":"Cui S, Xin W, Wang F et al (2024) Metabolic tumour area: a novel prognostic indicator based on (18)F-FDG PET\/CT in patients with diffuse large B-cell lymphoma in the R-CHOP era. BMC cancer Jul 25(1):895. https:\/\/doi.org\/10.1186\/s12885-024-12668-x","journal-title":"BMC cancer Jul"},{"issue":"1","key":"7272_CR15","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","volume":"1","author":"CP Hans","year":"2004","unstructured":"Hans CP, Weisenburger DD, Greiner TC et al (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood Jan 1(1):275\u2013282. https:\/\/doi.org\/10.1182\/blood-2003-05-1545","journal-title":"Blood Jan"},{"issue":"10","key":"7272_CR16","doi-asserted-by":"publisher","first-page":"e70283","DOI":"10.1002\/jgh3.70283","volume":"9","author":"T Alshamari","year":"2025","unstructured":"Alshamari T, Chong P, Yi LM, Pergassam D, Gnanendran D (2025) Primary Gastrointestinal Lymphoma: A Retrospective Cohort Study on Clinical Presentation, Treatment Outcomes, and Survival Trends With a Focus on Emergency Versus Elective Management. JGH open: open access J Gastroenterol hepatology Oct 9(10):e70283. https:\/\/doi.org\/10.1002\/jgh3.70283","journal-title":"JGH open: open access J Gastroenterol hepatology Oct"},{"issue":"23","key":"7272_CR17","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1182\/blood.2019002729","volume":"4","author":"AS Ruppert","year":"2020","unstructured":"Ruppert AS, Dixon JG, Salles G et al (2020) International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI. Blood Jun 4(23):2041\u20132048. https:\/\/doi.org\/10.1182\/blood.2019002729","journal-title":"Blood Jun"},{"key":"7272_CR18","doi-asserted-by":"publisher","unstructured":"Cheson BD (2015) Staging and response assessment in lymphomas: the new Lugano classification. Chinese clinical oncology. Mar ;4(1):5. https:\/\/doi.org\/10.3978\/j.issn.2304-3865.2014.11.03","DOI":"10.3978\/j.issn.2304-3865.2014.11.03"},{"key":"7272_CR19","doi-asserted-by":"publisher","unstructured":"Ying CL, Han DG, Tian LG, Tong QY, Liu W Clinical characteristics of primary gastrointestinal lymphoma presenting with gastrointestinal bleeding. Scandinavian J gastroenterology Apr 3 2026:1\u201310. https:\/\/doi.org\/10.1080\/00365521.2026.2652020","DOI":"10.1080\/00365521.2026.2652020"},{"key":"7272_CR20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12957-016-0821-9","volume":"14","author":"Z Ge","year":"2016","unstructured":"Ge Z, Liu Z, Hu X (2016) Anatomic distribution, clinical features, and survival data of 87 cases primary gastrointestinal lymphoma. World J Surg oncology Mar 18 14:85. https:\/\/doi.org\/10.1186\/s12957-016-0821-9","journal-title":"World J Surg oncology Mar 18"},{"issue":"11","key":"7272_CR21","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1245\/s10434-006-9069-x","volume":"13","author":"G Spectre","year":"2006","unstructured":"Spectre G, Libster D, Grisariu S et al (2006) Bleeding, obstruction, and perforation in a series of patients with aggressive gastric lymphoma treated with primary chemotherapy. Annals Surg oncology Nov 13(11):1372\u20131378. https:\/\/doi.org\/10.1245\/s10434-006-9069-x","journal-title":"Annals Surg oncology Nov"},{"issue":"5","key":"7272_CR22","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1053\/j.seminhematol.2023.12.003","volume":"60","author":"KL Lewis","year":"2023","unstructured":"Lewis KL, Trotman J (2023) Integration of PET in DLBCL. Seminars hematology Nov 60(5):291\u2013304. https:\/\/doi.org\/10.1053\/j.seminhematol.2023.12.003","journal-title":"Seminars hematology Nov"},{"issue":"2","key":"7272_CR23","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1136\/gutjnl-2011-300563","volume":"61","author":"HJ Andreyev","year":"2012","unstructured":"Andreyev HJ, Davidson SE, Gillespie C, Allum WH, Swarbrick E (2012) Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer. Gut Feb 61(2):179\u2013192. https:\/\/doi.org\/10.1136\/gutjnl-2011-300563","journal-title":"Gut Feb"},{"issue":"1","key":"7272_CR24","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41408-023-00930-7","volume":"13","author":"J Jelicic","year":"2023","unstructured":"Jelicic J, Juul-Jensen K, Bukumiric Z et al (2023) Prognostic indices in diffuse large B-cell lymphoma: a population-based comparison and validation study of multiple models. Blood cancer journal Oct 13(1):157. https:\/\/doi.org\/10.1038\/s41408-023-00930-7","journal-title":"Blood cancer journal Oct"},{"issue":"1","key":"7272_CR25","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1186\/s12885-023-11333-z","volume":"29","author":"F Wang","year":"2023","unstructured":"Wang F, Cui S, Lu L et al (2023) Dissemination feature based on PET\/CT is a risk factor for diffuse large B cell lymphoma patients outcome. BMC cancer Nov 29(1):1165. https:\/\/doi.org\/10.1186\/s12885-023-11333-z","journal-title":"BMC cancer Nov"},{"issue":"4","key":"7272_CR26","doi-asserted-by":"publisher","first-page":"536","DOI":"10.2967\/jnumed.122.264740","volume":"64","author":"L Michaud","year":"2023","unstructured":"Michaud L, Bantilan K, Mauguen A, Moskowitz CH, Zelenetz AD, Sch\u00f6der H (2023) Prognostic Value of (18)F-FDG PET\/CT in Diffuse Large B-Cell Lymphoma Treated with a Risk-Adapted Immunochemotherapy Regimen. Journal nuclear medicine: official publication Soc Nuclear Medicine Apr 64(4):536\u2013541. https:\/\/doi.org\/10.2967\/jnumed.122.264740","journal-title":"Journal nuclear medicine: official publication Soc Nuclear Medicine Apr"},{"issue":"12","key":"7272_CR27","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1080\/10428194.2025.2540442","volume":"66","author":"A Xiao","year":"2025","unstructured":"Xiao A, Chen L, Pak S et al (2025) Real-world infectious complications of CD3\/CD20 bispecific antibodies in relapsed\/refractory non-Hodgkin lymphoma. Leukemia & lymphoma Dec 66(12):2260\u20132268. https:\/\/doi.org\/10.1080\/10428194.2025.2540442","journal-title":"Leukemia & lymphoma Dec"},{"issue":"3","key":"7272_CR28","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1093\/annonc\/mdq403","volume":"22","author":"M Picardi","year":"2011","unstructured":"Picardi M, Soricelli A, Grimaldi F, Nicolai E, Gallamini A, Pane F (2011) Fused FDG-PET\/contrast-enhanced CT detects occult subdiaphragmatic involvement of Hodgkin\u2019s lymphoma thereby identifying patients requiring six cycles of anthracycline-containing chemotherapy and consolidation radiation of spleen. Annals oncology: official J Eur Soc Med Oncology Mar 22(3):671\u2013680. https:\/\/doi.org\/10.1093\/annonc\/mdq403","journal-title":"Annals oncology: official J Eur Soc Med Oncology Mar"},{"issue":"10","key":"7272_CR29","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/dc.21450","volume":"39","author":"P Zeppa","year":"2011","unstructured":"Zeppa P, Barra E, Napolitano V et al (2011) Impact of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) in lymph nodal and mediastinal lesions: a multicenter experience. Diagnostic cytopathology Oct 39(10):723\u2013729. https:\/\/doi.org\/10.1002\/dc.21450","journal-title":"Diagnostic cytopathology Oct"},{"key":"7272_CR30","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.2147\/cmar.S295671","volume":"13","author":"Y Shen","year":"2021","unstructured":"Shen Y, Ou J, Wang B, Wang L, Xu J, Cen X (2021) Influence of Severe Gastrointestinal Complications in Primary Gastrointestinal Diffuse Large B-Cell Lymphoma. Cancer Manag Res 13:1041\u20131052. https:\/\/doi.org\/10.2147\/cmar.S295671","journal-title":"Cancer Manag Res"},{"issue":"2","key":"7272_CR31","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s10620-016-4368-y","volume":"62","author":"RA Schatz","year":"2017","unstructured":"Schatz RA, Rockey DC (2017) Gastrointestinal Bleeding Due to Gastrointestinal Tract Malignancy: Natural History, Management, and Outcomes. Digestive Dis sciences Feb 62(2):491\u2013501. https:\/\/doi.org\/10.1007\/s10620-016-4368-y","journal-title":"Digestive Dis sciences Feb"},{"key":"7272_CR32","doi-asserted-by":"publisher","unstructured":"Kadota T, Seo S, Fuse H et al (Mar 2019) Complications and outcomes in diffuse large B-cell lymphoma with gastric lesions treated with R-CHOP. Cancer medicine. 8(3):982\u2013989. https:\/\/doi.org\/10.1002\/cam4.1982","DOI":"10.1002\/cam4.1982"},{"issue":"6","key":"7272_CR33","doi-asserted-by":"publisher","first-page":"6924","DOI":"10.1002\/cam4.5486","volume":"12","author":"L Zhang","year":"2023","unstructured":"Zhang L, Huang H, Wang Z et al (2023) A study on the prevention of hemorrhage and perforation in patients with primary gastric diffuse large-B cell lymphoma during treatment with immunochemotherapy. Cancer medicine Mar 12(6):6924\u20136934. https:\/\/doi.org\/10.1002\/cam4.5486","journal-title":"Cancer medicine Mar"},{"issue":"1","key":"7272_CR34","doi-asserted-by":"publisher","first-page":"e2022017","DOI":"10.4084\/mjhid.2022.017","volume":"14","author":"L Guarnera","year":"2022","unstructured":"Guarnera L, Meconi F, Secchi R et al (2022) Efficacy and Safety of Cyclophosphamide Low-Dose Pre-Phase Chemotherapy in Diffuse Large B Cell Lymphoma with Gastrointestinal Involvement. Mediterranean J Hematol Infect Dis 14(1):e2022017. https:\/\/doi.org\/10.4084\/mjhid.2022.017","journal-title":"Mediterranean J Hematol Infect Dis"},{"key":"7272_CR35","doi-asserted-by":"publisher","unstructured":"Sasaki Y, Matsunawa M, Hayashi H et al (2026) Comparison between Pola-R-CHP and R-CHOP regimens in patients newly diagnosed with diffuse large B-cell lymphoma: a propensity score-matched study. Scientific reports Jun 26. https:\/\/doi.org\/10.1038\/s41598-026-60010-1","DOI":"10.1038\/s41598-026-60010-1"},{"key":"7272_CR36","doi-asserted-by":"publisher","unstructured":"Akita K, Takahata A, Tokuyama W, Nakamura N, Toyota S (2026) Comparison of Pola-R-CHP and R-CHOP for newly diagnosed DLBCL: A single-center retrospective study. Journal Clin experimental hematopathology: JCEH Jul 30. https:\/\/doi.org\/10.3960\/jslrt.26017","DOI":"10.3960\/jslrt.26017"},{"issue":"5","key":"7272_CR37","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/bjh.18348","volume":"198","author":"M Picardi","year":"2022","unstructured":"Picardi M, Giordano C, Pugliese N et al (2022) Liposomal doxorubicin supercharge-containing front-line treatment in patients with advanced-stage diffuse large B-cell lymphoma or classical Hodgkin lymphoma: Preliminary results of a single-centre phase II study. British J haematology Sep 198(5):847\u2013860. https:\/\/doi.org\/10.1111\/bjh.18348","journal-title":"British J haematology Sep"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-07272-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07272-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07272-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T05:40:34Z","timestamp":1792647634000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-07272-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":37,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["7272"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-07272-x","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,14]]},"assertion":[{"value":"19 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This research plan was approved by the Ethics Committee of the First Affiliated Hospital of Wenzhou Medical University, and the research process strictly adhered to the principles of the \u201cHelsinki Declaration\u201d.","order":1,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was of a retrospective research nature. The review committee waived the patients\u2019 informed consent, but their privacies were still protected.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"474"}}